Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes
Enhanced Recovery Program, Patient Reported Outcomes, Surgery-specific Outcomes and Stress Response After Pancreatic Surgery: A Prospective Observational Cohort Study by the Thessalic Pancreas Study Group (ThePANas).
3 other identifiers
observational
120
1 country
1
Brief Summary
The purpose of this study is to evaluate the impact of compliance with enhanced recovery after surgery (ERAS) program on patient reported outcomes (PROs), surgery-specific outcomes and stress response after pancreatic surgery. This prospective observational study will include all consecutive patients undergoing pancreatic surgery over a period of three years (2022 - 2025) at two sites, namely University General Hospital of Larissa and IASO Thessalias, in Greece. Patients will be prospectively enrolled after written informed consent. Data will be collected on patient characteristics, surgical and anaesthetic techniques, complications, and length of stay. Quality of life questionnaires will be administered to patients preoperatively, on the fith postoperative day, first follow-up after discharge, one month and six months after the operation. The stress response will be assessed by measuring the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio (NLR and PLR) preoperatively, and on the first five postoperative days. Data will be collected on pancreatic surgery-specific complications such as delayed gastric emptying (DGE), post-pancreatectomy haemorrhage (PPH) and postoperative pancreatic fistula (POPF) formation. Anonymised data will be uploaded by the principal investigator on a protected excel spreadsheet for analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2022
CompletedFirst Submitted
Initial submission to the registry
August 21, 2022
CompletedFirst Posted
Study publicly available on registry
August 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedApril 22, 2025
April 1, 2025
2.8 years
August 21, 2022
April 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in patient-reported outcomes as measured by the Health Questionnaire EORTC QLQ-C30
This questionnaire assesses health related quality of life (HRQoL) for cancer patients and includes 30 questions. The QLQ-C30 includes five functional scales (physical, role, emotional, cognitive, and social functioning); eight symptom scales or single items (fatigue, pain, nausea/vomiting, dyspnea, insomnia, appetite loss, constipation, and diarrhea); an item to assess financial difficulties; 1 global health status scale; and 1 global quality of life scale. Each one of the first 28 items has 4 levels: 1 = not at all, 2 = a little, 3 = quite a bit, 4 = very much. The last 2 questions ask the patient to rate their own health and quality of life on a scale from 1 (very poor) to 7 (excellent). PROMs questionnaires will be distributed in paper format and filled out by pen.
1 week to 1 day before the operation, postoperative day 5, first follow-up 1 week post discharge, 1 month, and 6 months after the operation
Change on the stress response to surgery measured by the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratio (NLR and PLR).
NLR and PLR will be calculated by blood tests
1 week to 1 day before the operation, and postoperative days 1-5
Rate of Delayed Gastric Emptying (DGE)
Number of DGE defined and graded according to the International Study Group of Pancreatic Surgery (ISGPS).
within 6 weeks from operation
Rate of Post Pancreatic Fistula (POPF) formation
Number of POPF defined and graded according to the International Study Group of Pancreatic Fistula (ISGPF).
within 6 weeks from operation
Rate of Postoperative Pancreatic Haemorrhage (PPH)
Number of PPH defined and graded according to the International Study Group of Pancreatic Surgery (ISGPS).
within 6 weeks from operation
Secondary Outcomes (3)
Length of hospital stay (LOS)
within 6 weeks from operation
Overall morbidity rate
Within 3 months from operation
Cancer recurrence rate
within 1 year from operation
Interventions
ERAS protocol as described above
Eligibility Criteria
All consecutive community patients presented for pancreatic surgery
You may qualify if:
- all pancreatic surgery patients
- above the age of 18
- fluent greek speakers
- without communication barriers
You may not qualify if:
- younger than 18 years-old
- unable or unwilling to participate
- other surgical procedures
- communication barriers
- lost to follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Thessalylead
- IASO Thessaliascollaborator
- Larissa University Hospitalcollaborator
Study Sites (1)
University of Thessaly
Larissa, 45100, Greece
Related Publications (5)
Melloul E, Lassen K, Roulin D, Grass F, Perinel J, Adham M, Wellge EB, Kunzler F, Besselink MG, Asbun H, Scott MJ, Dejong CHC, Vrochides D, Aloia T, Izbicki JR, Demartines N. Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019. World J Surg. 2020 Jul;44(7):2056-2084. doi: 10.1007/s00268-020-05462-w.
PMID: 32161987BACKGROUNDSpolverato G, Maqsood H, Kim Y, Margonis G, Luo T, Ejaz A, Pawlik TM. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies. J Surg Oncol. 2015 Jun;111(7):868-74. doi: 10.1002/jso.23900. Epub 2015 Apr 10.
PMID: 25865111BACKGROUNDAaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. doi: 10.1093/jnci/85.5.365.
PMID: 8433390BACKGROUNDBujang MA, Sa'at N, Sidik TMITAB, Joo LC. Sample Size Guidelines for Logistic Regression from Observational Studies with Large Population: Emphasis on the Accuracy Between Statistics and Parameters Based on Real Life Clinical Data. Malays J Med Sci. 2018 Jul;25(4):122-130. doi: 10.21315/mjms2018.25.4.12. Epub 2018 Aug 30.
PMID: 30914854BACKGROUNDAustin PC, Steyerberg EW. Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models. Stat Methods Med Res. 2017 Apr;26(2):796-808. doi: 10.1177/0962280214558972. Epub 2014 Nov 19.
PMID: 25411322BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Despoina Liotiri, Consultant
University of Thessaly, IASO Thessalias
- STUDY CHAIR
Dimitrios Zacharoulis, Professor
University of Thessaly
- STUDY DIRECTOR
Eleni Arnaoutoglou, Professor
University of Thessaly
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, DESAIC, PgCert HBE(UK), EDRA, MSc, PhD(c), Consultant Anaesthesiologist
Study Record Dates
First Submitted
August 21, 2022
First Posted
August 26, 2022
Study Start
July 15, 2022
Primary Completion
May 1, 2025
Study Completion
June 1, 2025
Last Updated
April 22, 2025
Record last verified: 2025-04